How Wegovy affects weight — and what the evidence really shows

The biggest myth: Wegovy 'melts' fat automatically

A lot of what circulates online about Wegovy frames it as a passive fix, take the injection, wait, watch the scale fall. That is not how it works, and believing it sets people up for disappointment.

Wegovy activates the GLP-1 receptor, a pathway involved in signalling fullness and regulating blood sugar. The practical effect is that hunger quietens and meals feel satisfying sooner. What this creates is a reliable reduction in calorie intake, not a chemical process that dismantles fat cells independently of what you eat. Sustained weight loss still depends on the calorie gap that the appetite change makes easier to maintain.

This matters because people who go into treatment expecting a completely passive process sometimes do less of the lifestyle work, and that is precisely when results fall short. The STEP 1 trial, published in the New England Journal of Medicine, paired semaglutide with reduced-calorie dietary advice and increased activity guidance. The ~15% average weight loss figure comes from that combined context, and our Wegovy weight loss page explains what realistic outcomes look like in practice. Wegovy helps considerably; it does not act alone.

For practical guidance on getting the most from treatment, the how to lose weight on Wegovy page covers the lifestyle side in detail.

What the weight-loss trajectory actually looks like

Weight does not fall in a straight line on Wegovy, and the dose you start on is not the dose that drives the most change. The titration schedule begins at 0.25mg, a level chosen to let your body adjust, not to produce significant loss. Most of the meaningful reduction comes once you reach maintenance dose, typically 2.4mg, and continues for months beyond that.

In the STEP 1 trial, participants were still losing weight at week 60 of a 68-week study. There is often a plateau phase where loss slows before it resumes, which can be frustrating if you are not expecting it. This is normal physiology, not treatment failure.

The timeline for Wegovy weight loss sets out what to expect week by week. One thing worth knowing early: the most common side effects (nausea, loose stools, indigestion) tend to peak in the first few weeks after a dose increase and generally settle. Keeping your pen in the fridge door and injecting on the same day each week helps build the habit that carries you through the adjustment period.

If you are wondering whether you might gain weight when you stop, that is a separate and legitimate question covered on the what happens to weight after stopping Wegovy page.

Who the evidence applies to, and where the limits are

The STEP 1 trial enrolled adults with obesity or overweight plus at least one weight-related condition, without type 2 diabetes. Average outcomes from that group do not translate equally to every individual. Factors including starting weight, metabolic history, how consistently the lifestyle changes are maintained, and whether the full maintenance dose is reached all affect personal results.

The UK licence covers adults with a BMI of 30 or above, or 27 to 29.9 with at least one qualifying condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. Pregnancy, breastfeeding, and trying to conceive are situations where Wegovy is not recommended; the same applies to anyone under 18.

NICE's recommendation for semaglutide (TA875) sets out additional criteria for NHS access, including use within a specialist weight management service for a maximum of two years. NICE TA875 is the relevant document if you want to understand the NHS pathway in full. Private treatment through a regulated pharmacy follows the licensed eligibility criteria directly, assessed by a prescriber on a case-by-case basis.

For a broader overview of how semaglutide works and its full licensed profile, the semaglutide information page is a useful companion read. Details on what the cost of Wegovy through a private pharmacy covers are set out separately, including what a legitimate price should include beyond the medicine itself.

If you think Wegovy may be appropriate for you, speaking to a prescriber is the right next step. At nume, a GPhC-registered Independent Prescriber reads every consultation personally. Speak to our prescribers through a free consultation to find out whether you are clinically suitable.